Adam D. Cutler is Chief Financial Officer of Mural Oncology plc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Mural Oncology plc
18 Dec 23
3
Mural Oncology plc
15 Nov 23
4
InMed Pharmaceuticals Inc.
24 Jan 22
4
InMed Pharmaceuticals Inc.
30 Dec 21
4
Molecular Templates, Inc.
17 Feb 21
4
NAVIDEA BIOPHARMACEUTICALS, INC.
14 Jan 21
4
InMed Pharmaceuticals Inc.
18 Dec 20
3
InMed Pharmaceuticals Inc.
12 Nov 20
4
Molecular Templates, Inc.
18 Feb 20
4
NAVIDEA BIOPHARMACEUTICALS, INC.
7 Feb 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Dec 23 | MURA Mural Oncology | Ordinary Shares | Grant | Acquire A | No | No | 0 | 78,859 | 0.00 | 78,859 |
14 Dec 23 | MURA Mural Oncology | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 3.61 | 146,452 | 528.69 k | 146,452 |